The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
195 reports and counting
Candid Therapeutics raises $370M Series A at $1.2B valuation
Candid Therapeutics raises $370M in Series A at $1.2B valuation. Developing novel therapeutics for autoimmune diseases...
Candid Therapeutics Raises $370M in Series A
Candid Therapeutics, a Biotech company based in San Francisco, CA, has raised $370M in Series A at a $1.2B valuation led by Venrock, Fairmount, TCGX.
Candid Raises $200M in Series D
Candid, a AI/ML company based in San Francisco, CA, has raised $200M in Series D at a $1.5B valuation led by General Catalyst, Index Ventures.
Candid raises $200M Series D at $1.5B valuation
Candid raises $200M in Series D at $1.5B valuation. AI for business intelligence...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.